BACKGROUND: Gastro-oesophageal reflux disease (GERD) is a common disorder associated with substantial reductions in health-related quality of life (HRQL). AIM: To describe patterns of change in HRQL during 5 years of follow-up in a large population of GERD patients. METHODS: In 2000, a total of 6215 GERD patients were enrolled in the Progression of GERD (ProGERD) study. During follow-up, patients received any medication considered necessary. HRQL was assessed yearly with the Short-Form 36 and the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaires. Associations between patient characteristics and changes in HRQL were analysed using multiple logistic regression models. RESULTS: After 5 years, data on HRQL were available for 4597 (74%) patients. Both generic and disease-specific HRQL improved after baseline and remained well above baseline levels in the following years. A clinically relevant decrease in QOLRAD scores was reported by 3-5% of patients. According to our multivariate analysis, a decrease in HRQL was associated with a higher reflux symptom load and the presence of night-time heartburn. CONCLUSIONS: Only a small minority of the ProGERD population reported a clinically relevant decrease in HRQL, which was associated most strongly with nocturnal heartburn.
BACKGROUND:Gastro-oesophageal reflux disease (GERD) is a common disorder associated with substantial reductions in health-related quality of life (HRQL). AIM: To describe patterns of change in HRQL during 5 years of follow-up in a large population of GERDpatients. METHODS: In 2000, a total of 6215 GERDpatients were enrolled in the Progression of GERD (ProGERD) study. During follow-up, patients received any medication considered necessary. HRQL was assessed yearly with the Short-Form 36 and the Quality of Life in Reflux and Dyspepsia (QOLRAD) questionnaires. Associations between patient characteristics and changes in HRQL were analysed using multiple logistic regression models. RESULTS: After 5 years, data on HRQL were available for 4597 (74%) patients. Both generic and disease-specific HRQL improved after baseline and remained well above baseline levels in the following years. A clinically relevant decrease in QOLRAD scores was reported by 3-5% of patients. According to our multivariate analysis, a decrease in HRQL was associated with a higher reflux symptom load and the presence of night-time heartburn. CONCLUSIONS: Only a small minority of the ProGERD population reported a clinically relevant decrease in HRQL, which was associated most strongly with nocturnal heartburn.
Authors: Fermín Mearin; Julio Ponce; Marta Ponce; Agustín Balboa; Miguel A González; Javier Zapardiel Journal: World J Gastroenterol Date: 2012-09-21 Impact factor: 5.742
Authors: Katarzyna Blazejczyk; Andreas Hoene; Anne Glitsch; Alexandra Busemann; Claus Dieter Heidecke; Maciej Patrzyk Journal: Langenbecks Arch Surg Date: 2013-09-15 Impact factor: 3.445
Authors: Per G Farup; Ivar Blix; Sigurd Førre; Gjermund Johnsen; Ove Lange; Rune Johannessen; Hermod Petersen Journal: BMC Health Serv Res Date: 2011-05-20 Impact factor: 2.655
Authors: Sara Fill Malfertheiner; Maximilian V Malfertheiner; Siegfried Kropf; Serban-Dan Costa; Peter Malfertheiner Journal: BMC Gastroenterol Date: 2012-09-24 Impact factor: 3.067
Authors: Khean Lee Goh; Myung Gyu Choi; Ping I Hsu; Hoon Jai Chun; Varocha Mahachai; Udom Kachintorn; Somchai Leelakusolvong; Nayoung Kim; Abdul Aziz Rani; Benjamin C Y Wong; Justin Wu; Cheng Tang Chiu; Vikram Shetty; Joseph C Bocobo; Melchor M Chan; Jaw-Town Lin Journal: J Neurogastroenterol Motil Date: 2016-07-30 Impact factor: 4.924